Clinical Trials · NCT01028768

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

CompletedPhase 1Teduglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Nycomed
Enrollment
36
Start date
Oct 2009
Locations
1 site, Germany
Primary endpoint
Pharmacokinetics of teduglutide
View Teduglutide compound reference